Correlation between TILs and PD-1/PD-L1 expression is well studied, as tumor-associated inflammation promotes adaptive upregulation of immunosuppressive PD-L1 expression in response to anti-tumor immune cell production of IFN-γ and tumor cell STING pathway activation (22, 88). The gene discussed is STING1; the disease is neoplasm.